Skip to main content

ORBIMED ADVISORS LLC

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1055951 New York, NY

Position in BCRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$18,520,000
+$4,952,096 QoQ
Shares Held
1,852,000
+29.9% QoQ
Ownership
0.725%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#34
of 316 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 53% Shared 0% None 47%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ORBIMED ADVISORS LLC holds $67,146,504 across 4 Drug Manufacturers - Specialty & Generic names. BCRX ranks #2 (27.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 BCRX
Biocryst Pharmaceuticals Inc
This page
1,852,000 $18,520,000

All Filings in BCRX

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,520,000 1,852,000
2026-03-31 $13,567,904 1,425,200
2025-12-31 $13,586,040 1,741,800
2025-09-30 $6,842,385 901,500